Yu et al. focused on the CD68+/CD163+ macrophage (M2) subpopulation in oral SCCs, and they did not find a significant difference between HPV+ and HPV− oral SCC according to tumor progression and HPV status [57]. This evidence concerns the gene CD68 and neoplasm.